Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EQIX vs GSK✓SelectedUSD · GSKEQIX vs GSK performance historyLatest closeAs of-1.02%11/16
Stock and ETF performance explorer

EQIX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+239.3%
GSK return
+187.2%
Excess return
+52.1%
Maximum drawdown
-99.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.0%-0.1%-0.9%-1.0%
7D-1.1%-1.3%+0.2%-0.5%
30D+5.8%+2.7%+3.1%+4.3%
3M-4.9%+2.7%-7.6%-6.6%
6M-0.6%+3.3%-3.9%-3.2%
YTD+38.2%+6.5%+31.8%+31.5%
1Y+35.6%+10.7%+25.0%+26.5%
3Y+41.6%+64.4%-22.7%+4.2%
5Y+44.4%+46.7%-2.3%+10.0%
10Y+274.6%+109.4%+165.2%+128.0%
All+239.3%+187.2%+52.1%+38.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling